Patents by Inventor Guy Nys
Guy Nys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140057334Abstract: The present invention provides an agent that modulates physiological condition of pests, wherein the agent has an ability to modulate the activity of an insect choline acetyltransferase; a method for assaying pesticidal activity of a test substance, which comprises measuring the activity of a choline acetyltransferase in a reaction system in which the choline acetyltransferase contacts with a test substance, and the like.Type: ApplicationFiled: June 6, 2013Publication date: February 27, 2014Applicant: SUMITOMO CHEMICAL COMPANY, LIMITEDInventors: Junko OTSUKI, Marc Van De Craen, Annelies Roobrouck, Guy Nys, Bert Demey
-
Patent number: 8476035Abstract: The present invention provides an agent that modulates physiological condition of pests, wherein the agent has an ability to modulate the activity of an insect choline acetyltransferase; a method for assaying pesticidal activity of a test substance, which comprises measuring the activity of a choline acetyltransferase in a reaction system in which the choline acetyltransferase contacts with a test substance, and the like.Type: GrantFiled: November 21, 2008Date of Patent: July 2, 2013Assignee: Sumitomo Chemical Company, LimitedInventors: Junko Otsuki, Marc Van De Craen, Annelies Roobrouck, Guy Nys, Bert Demey
-
Publication number: 20120258929Abstract: The present invention provides an agent that modulates physiological condition of pests, wherein the agent has an ability to modulate the activity of an insect peptidyl-dipeptidase A; a method for assaying pesticidal activity of a test substance, which comprises a step of measuring the activity of a peptidyl-dipeptidase A in a reaction system in which the peptidyl-dipeptidase A contacts with a test substance, and the like.Type: ApplicationFiled: June 23, 2006Publication date: October 11, 2012Applicant: SUMITOMO CHEMICAL COMPANY, LIMITEDInventors: Yasutaka Shimokawatoko, Marc Van De Craen, Irene Nooren, Sandra Turconi, Yann Naudet, Guy Nys, Jurgen Debaveye
-
Publication number: 20110028423Abstract: The present invention provides an agent that modulates physiological condition of pests, wherein the agent has an ability to modulate the activity of an insect choline acetyltransferase; a method for assaying pesticidal activity of a test substance, which comprises measuring the activity of a choline acetyltransferase in a reaction system in which the choline acetyltransferase contacts with a test substance, and the like.Type: ApplicationFiled: November 21, 2008Publication date: February 3, 2011Applicant: SUMITOMO CHEMICAL COMPANY, LIMITEDInventors: Junko Otsuki, Marc Van De Craen, Annelies Roobrouck, Guy Nys, Bert Demey
-
Patent number: 7459292Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such- polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals). The invention further relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS4. The invention also relates to the identification of the cognate ligand of the IGS4 polypeptides of the invention.Type: GrantFiled: June 30, 2005Date of Patent: December 2, 2008Assignee: Solvay Pharmaceuticals, Inc.Inventors: Jakob Venema, Claudia Berger, Christiane Löken, Willy Deleersnijder, Guy Nys
-
Patent number: 7459279Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such- polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as G-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals). The invention further relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS4. The invention also relates to the identification of the cognate ligand of the IGS4 polypeptides of the invention.Type: GrantFiled: June 30, 2005Date of Patent: December 2, 2008Assignee: Solvay Pharmaceuticals, Inc.Inventors: Jakob Venema, Claudia Berger, Christiane Löken, Willy Deleersnijder, Guy Nys
-
Patent number: 7151165Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexposed or suppressed (knock-out animals).Type: GrantFiled: February 4, 2004Date of Patent: December 19, 2006Assignee: Solvay Pharmaceutical B.V.Inventors: Jakob Venema, Claudia Berger, Christiane Löken, Willy Deleersnijder, Guy Nys
-
Patent number: 6998255Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals).Type: GrantFiled: September 25, 2000Date of Patent: February 14, 2006Assignee: Solvay Pharmaceuticals B.V.Inventors: Willy Deleersnijder, Guy Nys, Jakob Venema, Claudia Berger, Christiane Löken
-
Publication number: 20050272123Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals).Type: ApplicationFiled: June 30, 2005Publication date: December 8, 2005Applicant: Solvay Pharmaceuticals B.V.Inventors: Jakob Venema, Claudia Berger, Christiane Loken, Willy Deleersnijder, Guy Nys
-
Publication number: 20050272122Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals).Type: ApplicationFiled: June 30, 2005Publication date: December 8, 2005Applicant: Solvay Pharmaceuticals B.V.Inventors: Jakob Venema, Claudia Berger, Christiane Loken, Willy Deleersnijder, Guy Nys
-
Publication number: 20050266529Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals).Type: ApplicationFiled: June 30, 2005Publication date: December 1, 2005Applicant: Solvay Pharmaceuticals B.V.Inventors: Jakob Venema, Claudia Berger, Christiane Loken, Willy Deleersnijder, Guy Nys
-
Publication number: 20040191797Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS1-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS1-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals). The invention further relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS1 and the use of IGS1 polypeptides and polynucleotides and agonists or antagonists to the IGS1 receptor family in the treatment of psychiatric and CNS disorders.Type: ApplicationFiled: December 10, 2003Publication date: September 30, 2004Applicant: Solvay Pharmaceuticals B.V.Inventors: Willy Deleersnijder, Guy Nys, Fan Zhang
-
Publication number: 20040175796Abstract: The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS4-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS4-gene is either overexpressed, misexpressed, underexposed or suppressed (knock-out animals).Type: ApplicationFiled: February 4, 2004Publication date: September 9, 2004Applicant: Solvay Pharmaceuticals, B.V.Inventors: Jakob Venema, Claudia Berger, Christiane Loken, Willy Deleersnijder, Guy Nys